Axsome Therapeutics Inc (STU:19X)
€ 81.28 -1.42 (-1.74%) Market Cap: 3.94 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 40.50 GF Score: 36/100

Axsome Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 01:20PM GMT
Release Date Price: €22.74 (+3.55%)
Unidentified Analyst

Okay. Good morning, everybody. Thanks for joining us in the next session. Pleased to have Axsome with us. Just quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures, or you can pick up a copy at the registration desk.

So I don't know if you want to make any opening comments before we get started?

Herriot Tabuteau
Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President

No. Just, I'd like to say thank you for having us at Morgan Stanley HealthCare Conference. I will be making forward-looking statements, so I do encourage you to read our SEC filings for a full description of the risks and uncertainties associated with our business.

Questions & Answers

Unidentified Analyst

Great. Good. So look, I thought it made sense to start with depression, and then we can talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot